The results of the study revealed that levels of irisin ≤ 4.15 ng/mL and its decrease > 20% from the baseline level showed independent discriminative potency for kidney-related events in T2DM patients with asymptomatic HF. This evidence concerns the gene FNDC5 and type 2 diabetes mellitus.